NCT05923216View on ClinicalTrials.gov

Induction of Sustained Unresponsiveness to Sesame Using High- and Low-dose Sesame Oral Immunotherapy

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Food Allergy
Interventions
DIETARY_SUPPLEMENT

High dose OIT

Patients will receive daily a high dose of the sesame paste (1200 mg sesame protein) mixed with well-tolerated fruit mousse or bread.

DIETARY_SUPPLEMENT

Low dose OIT

Patients will receive daily a low dose of the sesame paste (300 mg sesame protein) mixed with well-tolerated fruit mousse or bread.

Trial Locations (1)

02-091

Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER